Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 2
2009 1
2010 4
2011 3
2012 2
2013 4
2014 1
2015 1
2019 1
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.
Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa G, Paco S, Vila-Ubach M, Cuadrado-Vilanova M, Castillo-Ecija H, Botteri G, Garcia-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell M, Roldan M, König A, Suñol M, Claverol J, Lavarino C, Carmen de T, Fu L, Radvanyi F, Munier FL, Catalá-Mora J, Mora J, Alemany R, Cascalló M, Chantada GL, Carcaboso AM. Pascual-Pasto G, et al. Among authors: bazan peregrino m. Sci Transl Med. 2019 Jan 23;11(476):eaat9321. doi: 10.1126/scitranslmed.aat9321. Sci Transl Med. 2019. PMID: 30674657 Clinical Trial.
Gene therapy targeting to tumor endothelium.
Bazan-Peregrino M, Seymour LW, Harris AL. Bazan-Peregrino M, et al. Cancer Gene Ther. 2007 Feb;14(2):117-27. doi: 10.1038/sj.cgt.7701001. Epub 2006 Nov 10. Cancer Gene Ther. 2007. PMID: 17096029 Review.
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Farrera-Sal M, Moya-Borrego L, Bazan-Peregrino M, Alemany R. Farrera-Sal M, et al. Among authors: bazan peregrino m. Clin Cancer Res. 2021 Jun 1;27(11):2979-2988. doi: 10.1158/1078-0432.CCR-20-1565. Epub 2021 Feb 1. Clin Cancer Res. 2021. PMID: 33526422 Review.
Cavitation-enhanced extravasation for drug delivery.
Arvanitis CD, Bazan-Peregrino M, Rifai B, Seymour LW, Coussios CC. Arvanitis CD, et al. Among authors: bazan peregrino m. Ultrasound Med Biol. 2011 Nov;37(11):1838-52. doi: 10.1016/j.ultrasmedbio.2011.08.004. Epub 2011 Oct 2. Ultrasound Med Biol. 2011. PMID: 21963037
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.
Mato-Berciano A, Morgado S, Maliandi MV, Farrera-Sal M, Gimenez-Alejandre M, Ginestà MM, Moreno R, Torres-Manjon S, Moreno P, Arias-Badia M, Rojas LA, Capellà G, Alemany R, Cascallo M, Bazan-Peregrino M. Mato-Berciano A, et al. Among authors: bazan peregrino m. J Control Release. 2021 Apr 10;332:517-528. doi: 10.1016/j.jconrel.2021.02.035. Epub 2021 Mar 3. J Control Release. 2021. PMID: 33675877
Combining virotherapy and angiotherapy for the treatment of breast cancer.
Bazan-Peregrino M, Sainson RC, Carlisle RC, Thoma C, Waters RA, Arvanitis C, Harris AL, Hernandez-Alcoceba R, Seymour LW. Bazan-Peregrino M, et al. Cancer Gene Ther. 2013 Aug;20(8):461-8. doi: 10.1038/cgt.2013.41. Epub 2013 Jul 12. Cancer Gene Ther. 2013. PMID: 23846253
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page